Clinical Management of Immune-Mediated Liver Diseases
Nov
17
2024
Convention Center: Ballroom 6F
2:00 PM - 3:30 PM
Captured
World Class Speakers
Description
Presenters review the management of autoimmune-mediated liver diseases including autoimmune hepatititis, primary biliary cholangitis, primary sclerosing cholangitis, and immune-mediated DILI. The program also includes a panel discussion of a complex clinical case followed by a question-and-answer period.Journey Maps
Presentations
2:00 PM - 2:20 PM
Nov
17
2024
San Diego, CA
Autoimmune Hepatitis: Diagnosis, Treatment, and Management
Renee Pozza, PhD, FNP-BC, FAASLD, Presenter
Hepatology Associates
2:20 PM - 2:40 PM
Nov
17
2024
San Diego, CA
The Other Autoimmune Liver Diseases: Diagnosis and Management of Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
Ann Moore, FNP-C, Presenter
Hepatology Associates
2:40 PM - 3:00 PM
Nov
17
2024
San Diego, CA
Cannot Rule Out Drug-Induced/Toxic Injury: Immune-Mediated Drug-Induced Liver Injury
K. Tuesday T Werner, DNP-NP-C, AF-AASLD, Presenter
Hepatology Associates
3:00 PM - 3:30 PM
Nov
17
2024
San Diego, CA
Challenge the Panel: Complex Case Discussion
Moncheri Adebayo, MSN, CRNP, FNP-C, Presenter
Hepatology Associates
Objectives
- Review the pathophysiology of immune-mediated liver diseases.
- Describe appropriate diagnostic testing and criteria in the diagnosis of immune-mediated liver diseases.
- Identify treatment indications and appropriate pharmacologic therapies for the management of immune-mediated liver diseases.
Chair
Dawn Drazek, MSN, CRNP, AGPCNP-BC
Carolinas Medical Center